High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

Journal of Clinical Oncology

Volumn 16, Issue 3, 1998, Pages 1000-1007

  Ayash, Lois J ^a   Elias, Anthony ^a   Ibrahim, Joseph ^a   Schwartz, Gary ^a   Wheeler, Catherine ^a   Reich, Elaine ^a   Lynch, Cathy ^a   Warren, Diane ^a   Shapiro, Charles ^a   Richardson, Paul ^a   Hurd, David ^a   Schipper, Lowell ^a   Frei III, Emil ^a   Antman, Karen ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; MESNA; PROGESTERONE RECEPTOR; TAMOXIFEN; THIOTEPA;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BLOOD TOXICITY; BONE MARROW; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LYMPH NODE DISSECTION; MASTECTOMY; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031909620     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.3.1000     Document Type: Article

References (40)

1. Haagensen CD: Diseases of the Breast (ed 2) Philadelphia, PA, Saunders, 1971
2. Fisher B, Bauer M, Margolese R, et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985
3. Fisher B, Redmond C, Poisson R, et al: Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320:822-828, 1989
4. Veronesi U, Saccozzi R, DelVecchio M, et al: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancer of the breast. N Engl J Med 305:6-11, 1981
5. Hortobagyi GN, Blumenschein GR, Spanos W, et al: Multimodal treatment of locoregionally advanced breast cancer. Cancer 51:763-768, 1983
6. DeLena M, Varini M, Zucali R, et al: Multimodality treatment for locally advanced breast cancer. Cancer Clin Trials 4:229-230, 1981
7. Sheldon T, Hayes DF, Cady B, et al: Primary radiation therapy for locally advanced breast cancer. Cancer 60:1219-1225, 1987
8. DeLena M, Zucali R, Viganotti G, et al: Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharm 1:53-59, 1978
9. Buzdar AV, Montague ED, Barker JL, et al: Management of inflammatory carcinoma of breast with combined modality approach-an update. Cancer 47:2537-2542, 1981
10. Fastenberg NA, Buzdar AU, Montague ED, et al: Management of inflammatory carcinoma of the breast: A combined modality approach. Am J Clin Oncol 8:134-141, 1985
11. Schaake-Koning C, van der Linden EH, Hart G, et al: Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: A randomized clinical trial. Int J Radiat Oncol Biol Phys 11:1759-1763, 1985
12. Levine PH, Steinhorn SC, Ries LG, et al: Inflammatory breast cancer: The experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst 74:291-297, 1985
13. Rouesse BJ, Friedman S, Sarrazin D, et al: Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 4:1765-1771, 1986
14. Israel L, Breau J-L, Morere J-F: Two years of high-dose cyclophosphamide and 5-fluorouracil followed by surgery after 3 months for acute inflammatory breast carcinomas. Cancer 57:24-28, 1986
15. Feldman LD, Hortobagyi GN, Buzdar AU, et al: Pathologic assessment of response to induction chemotherapy in breast cancer. Cancer Res 46:2578-2581, 1986
16. Burton GV, Cox EB, Leight GS, et al: Inflammatory breast carcinoma: Effective multimodality approach. Arch Surg 122:1329-1332, 1987
17. Jacquillat CL, Baillet F, Weil M, et al: Results of a conservative treatment combining induction (neoadjuvant) and consolidation chemotherapy, hormonotherapy, and external and interstitial irradiation in 98 patients with locally advanced breast cancer (IIIA-IIIB). Cancer 61:1977-1982, 1988
18. Swain SM, Sorace RA, Bagley CS, et al: Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 47:3889-3894, 1987
19. Brun B, Otmezguine Y, Feuilhade F, et al: Treatment of inflammatory breast cancer with combination chemotherapy and mastectomy versus breast conservation. Cancer 61:1096-1103, 1988
20. Fields JN, Perez CA, Kuske RR, et al: Inflammatory carcinoma of the breast: Treatment results on 107 patients. Int J Radiat Oncol Biol Phys 17:249-255, 1989
21. Fields JN, Kuske RR, Perez CA, et al: Prognostic factors in inflammatory breast carcinoma: Univariate and multivariate analysis. Cancer 63:1225-1232, 1989
22. Thoms WW, McNeese MD, Fletcher GH, et al: Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys 17:739-745, 1989
23. Maloisel F, Dufour P, Bergerat JP, et al: Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer 65:851-855, 990
24. Elias EG, Vachon DA, Didolkar MS, et al: Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast. Am J Surg 162:231-235, 1991
25. Moore M, Ihde JK, Crowe JP, et al: Inflammatory breast cancer. Arch Surg 126:304-306, 1991
26. Lamb CC, Eberlein TJ, Parker LM, et al: Results of radical radiotherapy for inflammatory breast cancer. Am J Surg 162:236-242, 1991
27. Chevallier B, Bastit P, Graic Y, et al: The Centre H. Becquerel studies in inflammatory nonmetastatic breast cancer. Combined modality approach in 178 patients. Br J Cancer 67:594-601, 1993
28. Perez CA, Fields JN, Fracasso PM, et al: Management of locally advanced carcinoma of the breast: Inflammatory carcinoma. Cancer 74:466-476, 1994 (suppl)
29. Gardin G, Rosso R, Campora E, et al: Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer 31A:1428-1433, 1995
30. Chevallier B, Chollet P, Marrouche Y, et al: Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer. J Clin Oncol 13:1564-1571, 1995
31. Buzdar AU, Singletary SE, Booser DJ, et al: Combined modality treatment of stage III and inflammatory breast cancer. Surg Oncol Clin North Am 4:715-734, 1995
32. Jones RB, Holland JF, Bhardwaj S, et al: A phase I-II study of intensive-dose Adriamycin for advanced breast cancer. J Clin Oncol 5:172-177, 1987
33. Bronchud MH, Howell A, Crowther D, et al: The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer 60:121-125, 1989
34. Antman K, Ayash L, Elias A, et al: A phase II study of high dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy. J Clin Oncol 10:102-110, 1992
35. Elias AD, Ayash L, Anderson K, et al: Mobilization of peripheral blood progenitor cells by chemotherapy and GM-CSF for hematologic support after high-dose intensification for breast cancer. Blood 79:3036-3044, 1992
36. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 3:457-481, 1958
37. Armitage P, Berry G: Statistical Methods in Medical Research (ed 2). Oxford, United Kingdom, Blackwell Scientific, 1987
38. Bonadonna G, Veronesi V, Brambilla C, et al: Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539-1546, 1990
39. Riou G, Le MG, Travagli JP, et al: Poor prognosis of p53 nuclear overexpression and mutation in inflammatory breast cancer. Proc Am Soc Clin Oncol 13:81, 1994 (abstr 128)
40. Muss HB, Thor AD, Berry DA, et al: c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 330:1260-1266, 1994